查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014432

透析设备市场：依产品类型、治疗方法、模式和最终用户划分－2026-2032年全球市场预测

Dialysis Equipment Market by Product Type, Therapy Type, Modality, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年透析设备市值为280.2亿美元，预计2026年将成长至300.1亿美元，复合年增长率为7.33%，到2032年将达到459.8亿美元。

主要市场统计数据
基准年 2025 280.2亿美元
预计年份：2026年 300.1亿美元
预测年份 2032 459.8亿美元
复合年增长率 (%) 7.33%

本报告全面概​​述了临床因素、创新趋势、监管压力和战略重点，所有这些因素共同塑造了现代透析设备市场格局。

透析设备市场正处于临床需求、技术进步和不断演变的医疗服务模式的交汇点。慢性肾臟病病率的上升、对以病人为中心的照护日益重视，以及适宜的治疗方法向居家环境的转变，正在重塑医疗设备、耗材和配套基础设施的需求趋势和设计重点。同时，流体动力学、血管通路设计、水处理和数位监测平台的进步，使得治疗更加安全高效，同时也扩大了透析服务提供者的范围和地点。

家庭疗法的扩展、数位化整合、价值链韧性、基于价值的医疗保健奖励以及永续性考虑，正在推动行业变革。

透析设备产业正经历由临床创新、护理模式重组和技术融合所驱动的变革。患者对便利性和降低感染风险的需求，以及对易用性、便携性和远端监测功能的日益增长的需求，正在加速居家透析的普及。这项转变要求製造商优先考虑设备的便携性、简化的维护和符合人体工学的设计，以确保患者能够在医疗机构外安全独立地使用透析设备。

对 2025 年关税如何重塑透析设备产业的供应策略、采购实务、产品设计选择和跨部门合作进行全面评估。

美国将于2025年加征关税，这为透析设备相关人员的全球供应链、筹资策略和定价考量带来了新的复杂性。关税带来的成本压力迫使製造商和经销商重新评估其采购地点，考察替代供应商，并加快关于近岸外包和区域製造中心的讨论，以保持竞争力。这些策略性因应措施涉及营运方面的调整，例如重新谈判供应商合约、调整库存政策以及重组物流计划，以最大限度地降低关税波动带来的风险。

主导细分市场，将治疗亚型、产品类别、最终用户环境和治疗方法差异与临床要求、采购因素和产品蓝图选择连结起来，从而获得洞察。

要了解市场，需要具备细分观点临床实践模式与产品设计和分销管道连结起来。根据治疗方法类型，市场模式可大致分为血液透析和腹膜透析。血液透析本身可分为传统血液透析和线上血液透析滤过，这反映了溶质清除策略和系统复杂性的差异。腹膜透析进一步分为自动腹膜透析和持续性携带式腹膜透析，每种透析方式在病患训练、耗材使用和週期计要求方面均有所不同。这些治疗方法的差异导致了对设备、耗材和监测解决方案的需求差异，同时也影响临床路径和训练的投入。

关键区域资讯揭示了美洲、欧洲、中东和非洲以及亚太市场的需求推动要素、监管差异、基础设施发展和商业策略。

区域趋势塑造着不同地理区域的需求驱动因素、法律规范和医疗服务模式。在美洲，医疗体系融合了先进的医疗生态系统和多样化的报销机制，促进了居家照护和数位化监测的创新，同时高度重视成本控制和供应链可靠性。特定市场医疗网络的整合和集中采购为战略伙伴关係和配套服务协议创造了机会，这些合作和协议优先考虑总成本和临床疗效。

竞争情报着重于产品组合整合、数位化增强、优质服务和策略联盟，以此作为在透析设备市场中保持持续主导地位的决定因素。

透析设备产业的竞争动态取决于产品组合的广度、服务覆盖范围、合规性以及硬体和软体的创新能力。主要企业透过整合解决方案脱颖而出，这些解决方案将可靠的设备和高品质的耗材与强大的售后支援相结合，包括预防性保养计划、培训服务和数据驱动的性能优化。策略伙伴关係、OEM协议和分销合作正成为拓展服务覆盖范围、覆盖不同终端用户群体以及弥合区域服务差距的关键机制。

为製造商和供应商提供可操作的策略建议，以使其研发、经营模式和供应链韧性与不断变化的临床和报销要求保持一致。

产业领导企业必须采取果断行动，调整产品开发、商业策略和业务永续营运，以适应重塑透析照护的结构性变革。优先考虑“便于采用的设计”，在确保各种治疗亚型临床疗效的同时，兼顾人体工学、简化维护和直观的家用介面。投资于能够提供可操作的营运洞察、实现远端患者监护并支援基于结果的合约的数位化平台。这些功能可以将设备数据转化为可衡量的临床和经济价值。

对调查方法进行了清晰的概述，详细介绍了相关人员的参与、二手资讯的检验、检验协议以及用于得出战略见解的分析框架。

本执行摘要所依据的研究整合了第一手和第二手资料，从而得出可靠且可操作的结论。第一手资料包括对透析中心、医院和居家照护项目的临床医生、采购经理和技术运营人员进行的结构化访谈，以及与製造和分销公司高管的讨论。这些对话为设备可用性、可维护性、培训需求和采购决策标准提供了切实可行的观点。

总结了透析设备产业的策略见解、营运风险和优先行动，以指导经营团队决策和投资决策。

在对临床趋势、技术创新、监管变化和商业性压力进行全面分析后，透析设备行业的管理人员总结出几个关键的通用见解。首先，以病人为中心的照护模式和居家治疗的实现并非边缘趋势，而是产品设计和服务需求的核心驱动力。其次，数位化能力的提升正在将设备转变为平台，从而创造持续创收和与临床机构更紧密合作的机会。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 透析设备市场：依产品类型划分

  • 配件
    • 透析椅及透析床
    • 透析器再处理单元
    • 水处理系统
  • 消耗品
    • 血液迴路和装置
    • 透析液
    • 透析器
    • 静脉通路装置
  • 装置
    • 连续性肾臟替代治疗装置
    • 血液透析机
    • 腹膜透析週期计

第九章 依治疗方法分類的透析设备市场

  • 血液透析
    • 传统血液透析
    • 线上血液透析过滤
  • 腹膜透析
    • 自动化腹膜透析
    • 持续性门诊腹膜透析

第十章 透析设备市场：依模式划分

  • 持续治疗
    • 连续性肾臟替代疗法
    • 持续低效透析
  • 间歇性血液透析

第十一章 透析设备市场：依最终用户划分

  • 透析中心
  • 居家医疗
  • 医院

第十二章 透析设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 透析设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 透析设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国透析设备市场

第十六章 中国透析设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • AGC Engineering Co., Ltd.
  • Ameridia Innovative Solutions, Inc.
  • ASTOM Corporation
  • Bluestar（Beijing）Chemical Machinery Co., Ltd.
  • C-Tech Innovation Ltd.
  • Electrosynthesis Company, Inc.
  • Entegris, Inc.
  • Eurodia Industrie SA
  • Fujifilm Corporation
  • General Electric Company
  • Ion Exchange（India）Limited
  • JIUWU HI-TECH Co., Ltd.
  • Lenntech BV
  • Mega as
  • PCCell GmbH
  • Pure Water Group
  • Saltworks Technologies Inc.
  • Samco Technologies, Inc.
  • Shandong Tianwei Membrane Technology Co., Ltd.
  • SnowPure, LLC
  • Toray Industries, Inc.
  • Veolia Water Technologies
  • WGM Sistemas SA
  • Xylem Inc.
Product Code: MRR-4348D129FA1E

The Dialysis Equipment Market was valued at USD 28.02 billion in 2025 and is projected to grow to USD 30.01 billion in 2026, with a CAGR of 7.33%, reaching USD 45.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 28.02 billion
Estimated Year [2026] USD 30.01 billion
Forecast Year [2032] USD 45.98 billion
CAGR (%) 7.33%

A comprehensive introduction framing clinical drivers, innovation trends, regulatory pressures, and strategic priorities that collectively define the modern dialysis equipment landscape

The dialysis equipment landscape sits at the intersection of clinical necessity, technological advancement, and evolving care delivery models. Rising prevalence of chronic kidney disease, increasing emphasis on patient-centric care, and the migration of suitable therapies into home settings are collectively reshaping demand signals and design priorities for devices, consumables, and supportive infrastructure. In parallel, advances in fluidics, vascular access design, water treatment, and digital monitoring platforms are enabling safer, more efficient therapies while also broadening the scope of who can deliver dialysis and where it can be delivered.

Healthcare payers and providers are redefining value in renal care, prioritizing outcomes, cost efficiency, and patient experience. This shift is prompting manufacturers to rethink product portfolios, invest in modularity and interoperability, and pursue partnerships that span care delivery, telehealth integration, and home-care enablement. Regulatory environments and quality standards continue to tighten, creating both barriers and opportunities: robust compliance frameworks raise entry thresholds while simultaneously elevating the market value of proven, validated solutions.

The remainder of this executive summary synthesizes these dynamics into strategic implications, segmentation-based insights, regional patterns, competitive observations, and practical recommendations designed to inform decision-makers tasked with navigating rapid change in the dialysis equipment arena.

Transformative industry shifts driven by home therapy growth, digital integration, supply chain resilience, value-based care incentives, and sustainability considerations

The dialysis equipment sector is experiencing transformative shifts driven by clinical innovation, care model reorientation, and technological convergence. Home therapy adoption has accelerated, propelled by patient preference for convenience and infection-risk reduction, alongside improvements in device usability, compactness, and remote monitoring capabilities. This transition requires manufacturers to prioritize portability, simplified maintenance, and clear human factors engineering to enable safe, independent use outside institutional environments.

Concurrently, digital therapeutics and connected device ecosystems are reshaping product expectations. Embedded sensors, predictive maintenance, and cloud-based analytics support preventive interventions and operational efficiencies. These capabilities also create new commercial pathways through software-enabled services, subscription models for consumables, and outcomes-based contracting. Supply chain resilience has moved to the forefront, prompting diversification of sourcing, onshoring where feasible, and strategic stocking to mitigate disruptions.

Value-based care frameworks are incentivizing superior clinical outcomes and cost-effective therapy regimens. Providers are therefore seeking integrated solutions that reduce hospitalization, improve vascular access longevity, and optimize treatment customization. Finally, sustainability concerns are influencing design choices for consumables and water management, with lifecycle thinking increasingly informing procurement and regulatory dialogues. Together, these shifts demand that industry participants adopt more agile, patient-focused, and digitally-enabled product and commercial strategies.

An integrated assessment of how 2025 tariffs have reshaped supply strategies, procurement behavior, product design choices, and cross-functional alignment within the dialysis equipment landscape

The imposition of tariffs in 2025 within the United States has introduced a new layer of complexity for global supply chains, procurement strategies, and pricing considerations for dialysis equipment stakeholders. Tariff-related cost pressures have compelled manufacturers and distributors to revisit sourcing footprints, evaluate alternative suppliers, and accelerate discussions on nearshoring or regional manufacturing hubs to preserve competitive positioning. These strategic responses are accompanied by operational changes including renegotiated supplier contracts, adjusted inventory policies, and restructured logistics planning to minimize exposure to tariff volatility.

Procurement teams within healthcare systems have become more proactive in total-cost-of-ownership assessments, paying closer attention to the cumulative impact of import duties across machines, consumables, and accessories. This scrutiny has led to diversified supplier panels and an increased willingness to enter long-term agreements with manufacturers that can demonstrate supply certainty, quality compliance, and transparent cost structures. In parallel, product design teams are exploring material substitutions and modular architectures that reduce reliance on tariff-affected components without compromising clinical performance.

Clinicians and care managers are adjusting implementation timelines and capital procurement cycles to accommodate new vendor evaluations and pricing negotiations. Payers are observing these shifts and weighing implications for reimbursement policies, particularly where cost increases could threaten access or shift treatment modalities. Overall, the tariff environment has amplified the strategic importance of supply chain agility, vendor partnerships, and cross-functional alignment between commercial, regulatory, and operations teams.

Segmentation-driven insights that map therapy subtypes, product classes, end-user settings, and modality distinctions to clinical requirements, procurement drivers, and product roadmap choices

Understanding the market requires a segmentation-aware lens that links clinical practice patterns to product design and distribution channels. Based on therapy type, the landscape encompasses Hemodialysis and Peritoneal Dialysis. Hemodialysis itself divides into Conventional Hemodialysis and Online Hemodiafiltration, reflecting differences in solute removal strategies and system complexity; Peritoneal Dialysis further separates into Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis, each with distinct patient training, consumable usage, and cycler requirements. These therapy distinctions drive divergent demand for machines, consumables, and monitoring solutions, and they influence clinical pathways and training investments.

Based on product type, the ecosystem includes Accessories, Consumables, and Machines. Accessories span items such as dialysis chairs and beds, dialyzer reprocessing equipment, and water treatment systems that support safe and comfortable therapy delivery. Consumables encompass bloodlines and sets, dialysis fluids, dialyzers, and vascular access devices-components with high clinical sensitivity to material biocompatibility and manufacturing consistency. Machines cover continuous renal replacement therapy devices, hemodialysis machines, and peritoneal dialysis cyclers, each representing different complexity profiles, maintenance demands, and clinical settings of use.

Based on end users, care delivery settings include dialysis centers, home care settings, and hospitals, with each segment imposing unique operational requirements, staff competencies, and procurement channels. Based on modality, therapies are categorized into Continuous Therapies and Intermittent Hemodialysis, where Continuous Therapies include continuous renal replacement therapy and sustained low-efficiency dialysis; modality choices influence machine uptime expectations, consumable consumption patterns, and clinician staffing models. Mapping these segmentation dimensions against clinical outcomes and procurement behavior yields targeted product and go-to-market strategies.

Key regional intelligence that delineates demand drivers, regulatory variation, infrastructure readiness, and commercial tactics across Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics shape demand drivers, regulatory frameworks, and care delivery models across distinct geographies. In the Americas, health systems exhibit a mix of advanced care ecosystems and varying reimbursement landscapes that favor innovation in home therapies and digital monitoring, while also placing premium value on cost containment and supply chain reliability. Health network consolidation and centralized procurement in certain markets create opportunities for strategic partnerships and bundled-service contracts that emphasize total cost and clinical outcomes.

In Europe, Middle East & Africa, heterogeneous regulatory regimes and infrastructure maturity drive differentiated adoption patterns. Western European markets tend to prioritize clinical evidence, sustainability, and integrated care pathways, whereas parts of the Middle East and Africa face infrastructure constraints that prioritize robust, low-maintenance equipment and lifecycle service models. Reimbursement variability across the region necessitates adaptable commercial approaches, including flexible financing and local service partnerships to support market entry and scaled deployment.

In Asia-Pacific, rapid expansion of dialysis access, diverse payer systems, and a strong focus on domestic manufacturing competence present both opportunity and complexity. Demand in the region is influenced by growing urbanization, increasing chronic disease burden, and a competitive supplier landscape that includes both global OEMs and agile local manufacturers. Across these regions, differences in clinical guidelines, vascular access practice, and workforce availability directly affect product specification, training programs, and service models required for successful adoption.

Competitive intelligence that highlights portfolio integration, digital augmentation, service excellence, and strategic alliances as determinants of sustained advantage in dialysis equipment markets

Competitive dynamics in the dialysis equipment sector are shaped by portfolio breadth, service reach, regulatory track record, and the ability to innovate along both hardware and software dimensions. Leading companies differentiate through integrated offerings that combine reliable machines with high-quality consumables and robust post-sale support, including preventive maintenance programs, training services, and data-driven performance optimization. Strategic partnerships, OEM agreements, and distribution alliances have emerged as critical mechanisms to extend reach into diverse end-user segments and to bridge gaps in local service capabilities.

Innovation is not limited to device mechanics; companies that invest in digital platforms, remote monitoring, and telehealth integrations are building recurring-revenue models and deeper clinical ties. At the same time, there is a visible trend toward modular product architectures that simplify upgrades, reduce downtime, and enable component-level sourcing flexibility. Mergers and targeted acquisitions continue to be a strategic lever for accelerating access to complementary technologies, expanding consumables portfolios, and enhancing geographic presence.

Sustained competitive advantage will increasingly depend on cross-functional capabilities: regulatory excellence to accelerate market access, supply chain agility to withstand trade disruptions, clinical evidence generation to support adoption, and commercial models that align with payers' and providers' evolving expectations for value and outcomes.

Actionable strategic recommendations for manufacturers and providers to synchronize R&D, commercial models, and supply chain resilience with evolving clinical and reimbursement imperatives

Industry leaders must move decisively to align product development, commercial strategy, and operational resilience with the structural shifts reshaping dialysis care. Prioritize design-for-adoption that addresses home-use ergonomics, simplified maintenance, and intuitive interfaces while ensuring clinical efficacy across therapy subtypes. Invest in digital platforms that deliver actionable operational insights, enable remote patient monitoring, and support outcomes-based contracting; such capabilities can convert device data into measurable clinical and economic value.

Strengthen supply chain architecture by diversifying sourcing, establishing regional assembly or manufacturing capabilities where feasible, and negotiating flexible contractual terms that allocate tariff and logistics risks in transparent ways. Build service networks and training programs tailored to dialysis centers, hospitals, and home-care providers to reduce operational friction and accelerate clinician confidence. Pursue targeted partnerships and selective acquisitions that complement core capabilities-specifically in consumables, water treatment, or digital services-to create defensible, integrated solutions.

Finally, align engagement with payers and clinical leaders through evidence-generation programs that emphasize patient-centered outcomes, reduced hospitalizations, and cost-effective therapy pathways. This multi-pronged approach will enable organizations to capture emerging opportunities while mitigating regulatory, reimbursement, and supply-side risks.

A clear research methodology overview detailing stakeholder engagement, secondary source triangulation, validation protocols, and analytical frameworks employed to derive strategic insights

The research underpinning this executive summary synthesizes primary and secondary inputs to ensure robust, actionable conclusions. Primary inputs include structured interviews with clinicians, procurement leaders, and technical operations staff across dialysis centers, hospitals, and home-care programs, supplemented by discussions with manufacturing and distribution executives. These engagements provided practical perspectives on device usability, serviceability, training needs, and procurement decision criteria.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance documents, standards for water treatment and device safety, and publicly available technical specifications for machines and consumables. Data validation protocols included cross-referencing respondent statements with technical documentation and service records where available, and triangulating qualitative inputs with observed product features and regulatory filings.

Analytical frameworks applied causal mapping to connect clinical drivers with product requirements, scenario analysis to assess supply chain and tariff impacts, and segmentation matrices to align therapy types, product classes, end users, and modalities with commercial imperatives. Throughout, emphasis was placed on transparency of assumptions, traceability of evidence, and peer review by subject-matter experts to enhance credibility and relevance for executive decision-making.

Concluding synthesis of strategic takeaways, operational risks, and priority actions to guide executive decision-making and investment choices in the dialysis equipment sector

The synthesis of clinical trends, technological innovation, regulatory shifts, and commercial pressures yields several convergent takeaways for executive leaders in the dialysis equipment space. First, patient-centric care models and home therapy enablement are not peripheral trends but central drivers of product design and service requirements. Second, the rise of digital capabilities transforms devices into platforms, creating opportunities for recurring revenue and closer clinical integration.

Third, supply chain shocks and tariff changes underscore the need for resilient sourcing and flexible manufacturing footprints. Fourth, differentiation increasingly depends on integrated offerings that combine reliable hardware, high-quality consumables, and strong post-sale support. Finally, regional heterogeneity demands tailored market-entry strategies that reflect local infrastructure, reimbursement patterns, and clinical practice norms.

Taken together, these insights suggest that organizations that can rapidly adapt product design, commercial models, and operational capabilities to align with clinical realities and payer expectations will be best positioned to succeed. Executives should therefore prioritize cross-functional initiatives that bridge engineering, clinical affairs, supply chain, and commercial teams to translate strategic intent into measurable outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dialysis Equipment Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Dialysis Chairs And Beds
    • 8.1.2. Dialyzer Reprocessing Equipment
    • 8.1.3. Water Treatment Systems
  • 8.2. Consumables
    • 8.2.1. Bloodlines And Sets
    • 8.2.2. Dialysis Fluids
    • 8.2.3. Dialyzers
    • 8.2.4. Vascular Access Devices
  • 8.3. Machines
    • 8.3.1. Continuous Renal Replacement Therapy Devices
    • 8.3.2. Hemodialysis Machines
    • 8.3.3. Peritoneal Dialysis Cyclers

9. Dialysis Equipment Market, by Therapy Type

  • 9.1. Hemodialysis
    • 9.1.1. Conventional Hemodialysis
    • 9.1.2. Online Hemodiafiltration
  • 9.2. Peritoneal Dialysis
    • 9.2.1. Automated Peritoneal Dialysis
    • 9.2.2. Continuous Ambulatory Peritoneal Dialysis

10. Dialysis Equipment Market, by Modality

  • 10.1. Continuous Therapies
    • 10.1.1. Continuous Renal Replacement Therapy
    • 10.1.2. Sustained Low Efficiency Dialysis
  • 10.2. Intermittent Hemodialysis

11. Dialysis Equipment Market, by End Users

  • 11.1. Dialysis Centers
  • 11.2. Home Care Settings
  • 11.3. Hospitals

12. Dialysis Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Dialysis Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Dialysis Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Dialysis Equipment Market

16. China Dialysis Equipment Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AGC Engineering Co., Ltd.
  • 17.6. Ameridia Innovative Solutions, Inc.
  • 17.7. ASTOM Corporation
  • 17.8. Bluestar (Beijing) Chemical Machinery Co., Ltd.
  • 17.9. C-Tech Innovation Ltd.
  • 17.10. Electrosynthesis Company, Inc.
  • 17.11. Entegris, Inc.
  • 17.12. Eurodia Industrie S.A.
  • 17.13. Fujifilm Corporation
  • 17.14. General Electric Company
  • 17.15. Ion Exchange (India) Limited
  • 17.16. JIUWU HI-TECH Co., Ltd.
  • 17.17. Lenntech B.V.
  • 17.18. Mega a.s.
  • 17.19. PCCell GmbH
  • 17.20. Pure Water Group
  • 17.21. Saltworks Technologies Inc.
  • 17.22. Samco Technologies, Inc.
  • 17.23. Shandong Tianwei Membrane Technology Co., Ltd.
  • 17.24. SnowPure, LLC
  • 17.25. Toray Industries, Inc.
  • 17.26. Veolia Water Technologies
  • 17.27. WGM Sistemas S.A.
  • 17.28. Xylem Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIALYSIS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIALYSIS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CHAIRS AND BEDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CHAIRS AND BEDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CHAIRS AND BEDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZER REPROCESSING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZER REPROCESSING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZER REPROCESSING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY WATER TREATMENT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY WATER TREATMENT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY WATER TREATMENT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY BLOODLINES AND SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY BLOODLINES AND SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY BLOODLINES AND SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS FLUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS FLUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS FLUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY VASCULAR ACCESS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY VASCULAR ACCESS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY VASCULAR ACCESS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS CYCLERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS CYCLERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS CYCLERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY AUTOMATED PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY SUSTAINED LOW EFFICIENCY DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY SUSTAINED LOW EFFICIENCY DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY SUSTAINED LOW EFFICIENCY DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 194. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 195. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 196. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 198. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 199. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 200. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 201. GCC DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 224. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 227. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 228. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 229. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 232. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 233. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 234. G7 DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 238. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 239. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 240. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 242. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 243. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 245. NATO DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL DIALYSIS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA DIALYSIS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY MACHINES, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY HEMODIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY MODALITY, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY CONTINUOUS THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA DIALYSIS EQUIPMENT MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)